These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17131254)

  • 1. [Regression of lid-parallel conjunctival folds (LIPCOF) on topical treatment with Liposic Eye Gel--a pilot study].
    Höh H; Schwanengel M
    Klin Monbl Augenheilkd; 2006 Nov; 223(11):918-23. PubMed ID: 17131254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S; Dausch S; Maierhofer G; Dausch D
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study.
    Németh J; Fodor E; Lang Z; Kosina-Hagyó K; Berta A; Komár T; Petricek I; Higazy M; Prost M; Grupcheva C; Kemer OE; Schollmayer P; Samaha A; Hlavackova K
    Br J Ophthalmol; 2012 Nov; 96(11):1380-5. PubMed ID: 22952403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging lid-parallel conjunctival folds with OCT and comparing its grading with the slit lamp classification in dry eye patients and normal subjects.
    Veres A; Tapasztó B; Kosina-Hagyó K; Somfai GM; Németh J
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2945-51. PubMed ID: 21282573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The features of dry eye disease in a Japanese elderly population.
    Uchino M; Dogru M; Yagi Y; Goto E; Tomita M; Kon T; Saiki M; Matsumoto Y; Uchino Y; Yokoi N; Kinoshita S; Tsubota K
    Optom Vis Sci; 2006 Nov; 83(11):797-802. PubMed ID: 17106406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical tests for successful contact lens wear: relationship and predictive potential.
    Pult H; Purslow C; Berry M; Murphy PJ
    Optom Vis Sci; 2008 Oct; 85(10):E924-9. PubMed ID: 18832967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dry eye syndrome in rheumatoid arthritis patients].
    Polanská V; Hlinomazová Z; Fojtík Z; Nemec P
    Cesk Slov Oftalmol; 2007 Nov; 63(6):422-30. PubMed ID: 18062166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of dry eye disorders].
    Heiligenhaus A; Koch JM; Kemper D; Kruse FE; Waubke TN
    Klin Monbl Augenheilkd; 1994 Mar; 204(3):162-8. PubMed ID: 8196302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method to predict the dry eye symptoms in new contact lens wearers.
    Pult H; Murphy PJ; Purslow C
    Optom Vis Sci; 2009 Sep; 86(9):E1042-50. PubMed ID: 19668016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of bulbar conjunctival folds with other clinical findings in normal and moderate dry eye subjects.
    Miller WL; Narayanan S; Jackson J; Bergmanson J
    Optometry; 2003 Sep; 74(9):576-82. PubMed ID: 14515980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery.
    Li XM; Hu L; Hu J; Wang W
    Cornea; 2007 Oct; 26(9 Suppl 1):S16-20. PubMed ID: 17881910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.